<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M573</article-id>
      <article-id pub-id-type="publisher-id">molbank-2008-M573</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>3-(1-Phenyl-1<italic>H</italic>-pyrazol-4-yl)-1,2-benzisoxazole 2-oxide</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kotali</surname>
            <given-names>Antigoni</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2008-M573">Laboratory of Organic Chemistry, Department of Chemical Engineering, College of Engineering, University of Thessaloniki, Thessaloniki 54006, Greece E-mail: <email>kotali@eng.auth.gr</email></aff>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>08</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>08</month>
        <year>2008</year>
      </pub-date>
      <volume>2008</volume>
      <issue>2</issue>
      <elocation-id>M573</elocation-id>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>04</month>
          <year>2007</year>
        </date>
        <date date-type="rev-recd">
          <day>08</day>
          <month>08</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>08</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2008 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>(2-hydroxyphenyl)(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methanone oxime</kwd>
        <kwd>diacetoxy iodobenzene</kwd>
        <kwd>oxidation</kwd>
        <kwd>cyclisation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>It is well known that both isoxazole ring as well as pyrazole ring possess various biological activities and they both show interesting antimicrobial activity [<xref ref-type="bibr" rid="B1-molbank-2008-M573">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2008-M573">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2008-M573">3</xref>]. Therefore, it is not unreasonable to believe that a molecule bearing both moieties would possible show combined activity. Having this in mind we designed the synthesis of 3-(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)-1,2-benzisoxazole 2-oxide as shown below. Nitrogen derivatives of <italic>o</italic>-hydroxyaryl ketones have been proved valuable starting materials in organic synthesis[<xref ref-type="bibr" rid="B4-molbank-2008-M573">4</xref>]. Thus, we synthesised (2-hydroxyphenyl)(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methanone oxime and we subsequently oxidized it with diacetoxy iodobenzene (DIB). The reaction led to the formation of the oxidative cyclisation product, giving the desired 3-(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)-1,2-benzisoxazole 2-oxide, in 61% yield.
	  <disp-formula id="molbank-2008-M573-i001">
        <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M573-i001.tif"/>
        </disp-formula>
      (2-Hydroxyphenyl)(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methanone oxime was prepared according to the literature methods by refluxing (2-hydroxyphenyl)(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methanone and hydrochloric hydroxylamine in ethanol in the presence of pyridine whereas commercially available diacetoxy iodobenzene were supplied by Aldrich.</p>
    <sec>
      <title>Oxidation of (2-hydroxyphenyl)(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methanone oxime</title>
      <p>0.58 g (1.79 mmol) of DIB are added to a suspension of 0.5 g (1.79 mmol) of (2-hydroxyphenyl)(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methanone oxime in 20 ml CH<sub>2</sub>Cl<sub>2</sub> in an ice-bath. The mixture was then magnetically stirred for 3 hrs. Evaporation of the solvent gave an oil which was then subjected to column chromatography (silica gel 70-230 mesh). Elution with a mixture of petroleum ether / ethylacetate 3:1 afforded the desired 3-(1-phenyl-1<italic>H</italic>-pyrazol-4-yl)-1,2-benzisoxazole 2-oxide as white crystals (0.30 g, 61 %). The product was identified by its <sup>1</sup>H NMR, <sup>13</sup>C NMR and MS and elemental analysis. </p>
      <p>M.p. 179-180 &#xB0;C.</p>
      <p><sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>): 7.44-7.52 (m, 3H), 7.58-7.70 (m, 3H), 8.04-8.07(m, 2H), 8.32-8.34(d, <italic>J</italic>=8.0Hz, 1H), 8.67(s, 1H), 9.36(s, 1H).</p>
      <p><sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>): 107.7, 109.5, 118.9, 119.9, 120.1, 121.6, 125.1, 127.3, 127.7, 128.1, 129.6, 130.2, 139.5, 139.7, 149.1, 150.5.</p>
      <p>MS <italic>m/z</italic> (ES+): 300 [M+Na]<sup>+</sup>, 277 [M]<sup>+</sup>, 261, 247.</p>
      <p>Anal. Calc. for C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub>: C 69.31, H 4.00, N 15.15; found: C 69.22, H 3.88, N, 15.10</p>
    </sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2008-M573">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2008-M573-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M573-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2008-M573-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M573-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2008-M573">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Priya</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Bassappa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nanjunda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rangappa</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <source>Biorganic and Med. Chem.</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>2623</fpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2005.01.026</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2008-M573">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menozzi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Merello</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Fossa</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Schenome</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ranise</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mosti</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bondavalli</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Loddo</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Murgioni</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mascia</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>La Colla</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Tamburini</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <source>Bioorg. Med. Chem.</source>
          <year>2004</year>
          <volume>12</volume>
		  <issue>20</issue>
          <fpage>5465</fpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2004.07.029</pub-id>
          <pub-id pub-id-type="pmid">15388173</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2008-M573">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bekhit</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Ashour</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Guemei</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <source>Arch Pharm (Weinheim)</source>
          <year>2005</year>
          <volume>338</volume>
		  <issue>4</issue>
          <fpage>167</fpage>
          <pub-id pub-id-type="pmid">15864786</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2008-M573">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kotali</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <source>Org. Prep. Proc. Int.</source>
          <year>1994</year>
          <volume>26</volume>
		  <issue>2</issue>
		  <fpage>155</fpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
